Skip to main content

Table 4 Subgroup analyses in the intention-to-treat group, to be presented as forest plots

From: Evaluating the efficacy and safety of GKT137831 in adults with type 1 diabetes and persistently elevated urinary albumin excretion: a statistical analysis plan

SubgroupNumber (%)Estimated mean differencea95% Confidence IntervalP value
Intervention (GKT137831) group (n = xxx)Placebo group (n = xxx)
Sex
 Male     
 Female     
Age
 < median     
 ≥ median     
Diabetes mellitus duration
 < median     
 ≥ median     
BMI
 < median     
 ≥ median     
HbA1c
 < median     
 ≥ median     
  1. BMI body mass index, HbA1c glycated haemoglobin
  2. a In the intervention group compared to placebo